The book contains a preface and a final chapter that are basically editorials that make these points; the book consists largely of case discussions, reanalysis of data, and historical statements about the development and marketing of SSRIs. The problem is that it is difficult to read these with the belief that the author is presenting a dispassionate historical account or an objective look at clinical cases, the literature, or data analysis. It is very clear that Healy has an agenda, and he takes every opportunity to reinforce that agenda. He tends to make sweeping statements, with lots of "evidence" that may be a peer-reviewed journal article but also may turn out to be a quote from a colleague or a line from one of the many anti-Prozac books. He also tends to exaggerate many facts in his favor—for example, a characterization of the American Psychiatric Association's annual meeting that is correct in some respects but quite inaccurate in others.